AI assistant
NEOGENOMICS INC — Director's Dealing 2020
Jan 3, 2020
32227_dirs_2020-01-02_697611ea-dd64-47ce-a1c0-21da3de89ce7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2019-12-30
Reporting Person: JONES STEVEN C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-12-30 | Common Stock | M | 100000 | $4.78 | Acquired | 1625000 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-12-30 | Stock Option (Right to Buy) | $4.78 | J | 225000 | Disposed | 2020-05-04 | Common Stock (225000.0) | Direct |
| 2019-12-30 | Stock Option (Right to Buy) | $4.78 | J | 225000 | Acquired | 2020-05-04 | Common Stock (225000.0) | Indirect |
| 2019-12-30 | Stock Option (Right to Buy) | $4.78 | M | 100000 | Disposed | 2020-05-04 | Common Stock (100000.0) | Indirect |
| 2019-12-30 | Stock Option (Right to Buy) | $7.15 | J | 100000 | Disposed | 2021-04-20 | Common Stock (100000.0) | Direct |
| 2019-12-30 | Stock Option (Right to Buy) | $7.15 | J | 100000 | Acquired | 2021-04-20 | Common Stock (100000.0) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 43057 | Indirect |
| Common Stock | 50476 | Indirect |
| Common Stock | 150000 | Indirect |
| Common Stock | 195234 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $7.27 | 2022-05-25 | Common Stock (10000.0) | 10000 | Direct |
| Stock Option (Right to Buy) | $11.6 | 2023-06-01 | Common Stock (3017.0) | 3017 | Direct |
| Stock Option (Right to Buy) | $22.52 | 2026-06-06 | Common Stock (4269.0) | 4269 | Direct |
Footnotes
F1: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.
F2: On December 30, 2019, Mr. Jones transferred this option to Aspen Select Opportunity Fund, LP as part of estate planning activities.
F3: On May 4, 2015, Mr. Jones was granted 225,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F4: On April 20, 2016, Mr. Jones was granted 100,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F5: On May 25, 2017, Mr. Jones was granted 10,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.